Poulvac P Canary Lyofilisaat en oplosmiddel voor suspensie voor injectie
Poulvac P Canary Lyofilisaat en oplosmiddel voor suspensie voor injectie
Not authorised
- Canarypox virus, strain KP1, Live
Product identification
Medicine name:
Poulvac P Canary Lyofilisaat en oplosmiddel voor suspensie voor injectie
Poulvac P Canary Lyophilisat et solvant pour suspension injectable
Poulvac P Canary Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
- Canarypox virus, strain KP1, Live
Target species:
-
Finch
-
Common canary
Route of administration:
-
Wing-web-stab use
Product details
Active substance and strength:
-
Canarypox virus, strain KP1, Live4.00/log 10 50% embryo infective dose1.00Other
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01KD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Poulvac P Canary Poulvac P Canary 50 doses Vial Lyophilisate and solvent for suspension for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V127023
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
